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Pnhibition of Mitochondrial
ermeability Transition Prevents
epsis-Induced Myocardial Dysfunction and Mortality
érome Larche, MD,*† Steve Lancel, PHD,*† Sidi Mohamed Hassoun,*† Raphael Favory, MD,*†
rigitte Decoster, PHD,*† Philippe Marchetti, MD, PHD,‡ Claude Chopin, MD,*
emi Neviere, MD, PHD*†
ille, France
OBJECTIVES The purpose of this study was to test whether mitochondrial dysfunction is causative of sepsis
sequelae, a mouse model of peritonitis sepsis induced by cecal ligation and perforation.
Inhibition of mitochondrial permeability transition was achieved by means of pharmacolog-
ical drugs and overexpression of the antiapoptotic protein B-cell leukemia (Bcl)-2.
BACKGROUND Sepsis is the leading cause of death in critically ill patients and the predominant cause of multiple
organ failure. Although precise mechanisms by which sepsis leads to multiple organ dysfunction
are unknown, growing evidence suggests that perturbations of key mitochondrial functions,
including adenosine triphosphate production, Ca2 homeostasis, oxygen-derived free radical
production, and permeability transition, might be involved in sepsis pathophysiology.
METHODS Heart and lung functions were evaluated respectively by means of isolated heart preparation,
bronchoalveolar lavage fluid protein concentration, lung wet/dry weight ratio, lung homog-
enate myeloperoxidase activity, and histopathologic grading. Respiratory fluxes, calcium
uptake, and membrane potential were evaluated in isolated heart mitochondria.
RESULTS Peritonitis sepsis induced multiple organ dysfunction, mitochondrial abnormalities, and
increased mortality rate, which were reduced by pharmacological inhibition of mitochondrial
transition by cyclosporine derivatives and mitochondrial Bcl-2 overexpression.
CONCLUSIONS Our study provides strong evidence that mitochondrial permeability transition plays a critical role
in septic organ dysfunction. These studies demonstrate that mitochondrial dysfunction in sepsis
is causative rather than epiphenomenal and relevant in terms of vital organ function and outcome.
Regarding the critical role of heart failure in the pathophysiology of septic shock, our study also
indicates a potentially new therapeutic approach for treatment of sepsis syndrome. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.069Cardiol 2006;48:377–85) © 2006 by the American College of Cardiology Foundation
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tepsis is the systemic inflammatory response associated with
ram-negative, gram-positive, and fungal infections. An
stimated 750,000 cases of severe sepsis occur each year in
he U.S., causing 210,000 deaths annually (1). Once severe
epsis is recognized, development of cardiovascular failure is
ssociated with high mortality rates that have been esti-
ated to be 30% to 60% (2). The majority of septic patients
ie of refractory hypotension and cardiovascular collapse.
roposed mechanisms of sepsis-induced cardiovascular dys-
unction include microvascular dysfunction, presence of
ctivated leukocytes, and effects of various circulating and/or
ocally produced proinflammatory cytokines, such as tumor
ecrosis factor (TNF)-alpha and interleukin-1-beta (1,2).
n addition, recent evidence suggests that severity of myo-
ardial dysfunction and eventual mortality could be related
o mitochondrial dysfunction (3–7). Indeed, both human
epsis and experimental models of sepsis manifest evidence
f mitochondrial ultrastructural damage and bioenergetic
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arche and Lancel contributed equally to this work.c
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006, accepted February 28, 2006.bnormalities that correlate with septic response severity
4–7). Unresolved issues include, however, the need to
stablish that mitochondrial dysfunction is causative rather
han epiphenomenal and to determine how relevant these
bnormalities are in terms of vital organ function and outcome.
Manifestations of mitochondrial dysfunction are typically
eflected in ultrastructural damage and swelling, often asso-
iated with membrane potential collapse and permeability
ransition (3,8). Mitochondrial permeability transition has
een associated with matrix swelling, uncoupling of the
espiratory chain, efflux of Ca2, membrane potential col-
apse, and release of small proteins such as cytochrome c
8,9). Mitochondrial permeability transition is thought to be
ediated by the opening of specific high-conductance
hannels, whose molecular structure remains imperfectly
nown (10). Key structural components of these multipro-
ein complex channels are adenine nucleotide translocator in
he inner mitochondrial membrane, cyclophilin D in the
atrix, and the voltage-dependent anion channel in the
uter mitochondrial membrane (11–13). Cyclosporine A
CsA), a potent immunosuppressive compound, inhibits
itochondrial permeability transition by binding to matrix
yclophilin D (14,15). Other inhibitors of permeability
ransition pore opening include non-immunosuppressive
yclosporine analogs, bongkrekic acid and anti-apoptotic
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Mitochondrial Dysfunction in Septic Heart July 18, 2006:377–85-cell leukemia (Bcl) proteins, such as Bcl-2 and Bcl-xL
10). The relevance of mitochondrial permeability transition
nhibition by cyclosporine analogs for their cytoprotective
ffects is well documented in many cellular models (11–13).
echanisms of action in vivo are more difficult to define,
nd accordingly the evidence is as yet less compelling in
nimal models of ischemia/reperfusion injury (14,15),
rauma (16), and sepsis (6).
Hence, the specific objective of our study was to test
hether inhibition of permeability transition achieved by
eans of immunosuppressive and non-immunosuppressive
nalogs of CsA and mitochondrial Bcl-2 protein overex-
ression would improve vital organ dysfunction and out-
ome in a mouse model of peritonitis chronic sepsis.
ETHODS
nimals used. All experiments were conducted in accor-
ance with the National and European Institutes of Health
uidelines for the use of laboratory animals and were
pproved by the Lille University. The investigation con-
orms to the Guide for the Care and Use of Laboratory
nimals published by the U.S. National Institutes of Health
NIH Publication No. 85-23, revised 1996). In brief, 6- to
0-week-old female C57Bl/6 mice (Charles Rivers Labo-
atories, Lyon, France) and Bcl-2 transgenic mice were
oused for 6 days before manipulation. Transgenic mice
verexpressing human Bcl-2 (Bcl-2-22, CDTA Institut de
ransgénose CNRS, Orléans, France) were generated on a
57Bl/6 background. All animals in the study were
creened for the presence of Bcl-2 transgene by using
olymerase chain reaction with tail deoxyribonucleic acid.
epsis model. Cecal ligation and puncture (CLP) was used
o induce intra-abdominal peritonitis and sepsis as previ-
usly described (17). Under anesthesia (intraperitoneal [IP]
etamine 2.5 mg/kg and xylazine 0.25 mg/kg), the cecum was
igated with 4-0 silk suture immediately distal to the ileocecal
alve, punctured once with a 21-gauge needle and gently
queezed to extrude some stool. The cecum was then replaced
nto the abdomen, which was closed in two layers, followed by
 1.0-ml subcutaneous injection of 0.9% saline. Sham-operated
nimals were treated identically, except the cecum was neither
igated nor punctured. Animals were maintained on 12-h
Abbreviations and Acronyms
BALF  bronchoalveolar lavage fluid
Bcl  B-cell leukemia
CLP  cecal ligation and puncture
CsA  cyclosporine A
m  mitochondrial transmembrane potential
MPO  myeloperoxidase
NIM811  N-methyl-4-isoleucine cyclosporine
RCR  respiratory control ratio
TNF  tumor necrosis factor
TPP  tetraphenylphosphoniumight/dark cycles with free access to water. Animal treatments. Mice were treated immediately after
urgery procedures. Sham and CLP C57Bl/6 wild-type mice
ere randomized to receive 1.0-ml subcutaneous injection of
ither: 1) vehicle (1% ethanol in saline); 2) 2, 10, and 100
g/kg CsA (a potent immunosuppressive drug that also
nhibits mitochondrial permeability transition); 3) 2 mg/kg
acrolimus FK506 (a potent immunosuppressive drug that has
o effects on mitochondrial permeability transition); or 4) 2,
0, and 100 mg/kg N-methyl-4-isoleucine CsA (Novartis,
asel, Switzerland) NIM811 (a non-immunosuppressive
rug that inhibits mitochondrial permeability transition) in
ehicle. Sham and CLP Bcl-2 transgenic mice received
.0-ml injection of vehicle.
urvival studies. Survival studies after CLP were repeated
wice. An investigator blinded to the identity of the mice
erformed a 96-h follow-up both in wild-type and in Bcl-2
ransgenic mice in two separate experiments with 12 mice per
roup.
yocardial function. Isolated heart preparation was per-
ormed with a method modified for the mouse heart (18).
ice were anesthetized with sodium pentobarbital (65
g/kg IP), and heparin (100 U) was injected intravenously.
he thorax was opened. The heart was quickly excised,
laced in ice-cold saline, and immediately mounted, via the
scending aorta, onto a perfusion apparatus. The heart was
erfused with a nonrecirculating perfusate at a constant flow
1.5  0.1 ml/min). Coronary flow and coronary perfusion
ressure were measured with a transit-time ultrasound
owmeter (Transonic, Ithaca, New York) and pressure
ransducers (Baxter Healthcare Corp., Irvine, California). A
etal hook was inserted into the apex of the heart to control
nd record tension and heart rate. Tension was measured
ith a UF1 dynamometer transducer (UF1 BS4, Harvard
pparatus, Les Ulis, France). Transducers were calibrated
nd connected to a ML118 bridge amplifier that fed into a
owerlab 8 SP high-performance data acquisition system
ADInstruments Ltd. by Phymep, Paris, France).
eart mitochondrial function. MITOCHONDRIAL RESPI-
ATION STUDIES. Mouse heart was placed in isolation
uffer A containing (in mmol/l): sucrose 300, TES 5,
GTA 0.2, pH 7.2 (4°C). The tissue was finely minced and
omogenized by the use of a Kontes tissue grinder. After
00-g centrifugation for 5 min, supernatant was centrifuged
t 8,800 g for 5 min. Mitochondrial pellet was resuspended
n buffer A and centrifuged one more time at 8,800 g for 5
in. Protein concentration was determined according to the
radford method. Purity and integrity of isolated mito-
hondria were assessed by measuring specific activities of
icotinamide adenine dinucleotide phosphate-cytochrome c
eductase, as an endoplasmic reticulum marker enzyme, and
ytochrome c oxidase, as an inner membrane marker en-
yme (19).
For respiration studies, 200 g/ml mitochondria were sus-
ended in respiration medium MiR05 (20). The following
arameters of mitochondrial respiration (Oroboros, Innsbruck,
ustria) were evaluated: state 4 respiration rate (oxygen
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July 18, 2006:377–85 Mitochondrial Dysfunction in Septic Heartptake with glutamate 5 mmol/l malate 2 mmol/l in the
bsence of exogenous ADP; pmol oxygen/s/mg); state 3
espiration rate (oxygen uptake during ADP 1 mmol/l
hosphorylation; pmol oxygen/s/mg); and respiratory
ontrol ratio (RCR): ratio of state 3 and state 4 oxygen
ptake rates. In addition, we distinguish respiration with
lutamate malate as flux through the respiratory chain
rom complex I to IV and respiration with N,N,N=,N=-
igure 1. Survival rate of different groups of mice: survival rate of mice u
ith that of animals treated with 2, 10, and 100 mg/kg cyclosporine A (Aell leukemia (Bcl)-2 had a survival rate of 80% (C). Sample size is 12 in each grou
r transgenic CLP mice; †p  0.05, CLP versus treatment or transgenic CLPetramethyl-p-phenylenediamine (TMPD) (0.5 mmol/l)
scorbate (2 mmol/l) (after rotenone complex I inhibi-
ion) as maximum flux through the isolated step of com-
lex IV (20).
ITOCHONDRIAL PERMEABILITY TRANSITION AND TRANS-
EMBRANE POTENTIAL. These parameters were assessed
ollowing Ca2 overload as previously described (14,21). In
oing cecal ligation and puncture without treatment (CLP) was compared
-methyl-4-isoleucine cyclosporine (NIM811) (B). Mice overexpressing Bnderg
) or Np. Survival studies were conducted twice. *p 0.05, sham versus treatment
mice, by Kaplan-Meier, log-rank.
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Mitochondrial Dysfunction in Septic Heart July 18, 2006:377–85rief, isolated mitochondria (1 mg/ml proteins) were sus-
ended in buffer C (in mmol/l): sucrose 250; Tris-MOPS
0; glutamate-Tris 5; malate-Tris 2; Pi-Tris 1; EGTA-Tris
.02; pH 7.4 at 25°C in a multiport measurement chamber
NOCHM-4, WPI, Aston, United Kingdom) equipped
ith Ca2, tetraphenylphosphonium (TPP)-selective mi-
roelectrodes, and reference electrodes (WPI), as previously
escribed (14,21). First, mitochondria were gently stirred
or 1.5 min in buffer C containing 1.5 mol/l TPP
Sigma, Saint Quentin Fallavier, France). At the end of the
re-incubation period, 10 mol/l CaCl2 administration was
erformed every 90 s with a micro syringe injector adapted
o a Micro4 pump controller (UMPII and Micro4, WPI).
ach 10-mol/l CaCl2 pulse was detected as a peak of
xtramitochondrial Ca2 concentration. The Ca2 is then
ery rapidly taken up by the mitochondria resulting in a
eturn of extramitochondrial Ca2 concentration to near
aseline level (13,14). The mitochondrial transmembrane
otential was estimated by calculating the transmembrane
istribution of TPP. Transmembrane potential m was
alculated as 59log(v/V)  59log(10E/59  1), where v is
atrix volume (1.1 l/mg mitochondrial protein), V is
olume chamber (1 ml), and E is voltage difference before
nd after permeability transition pore opening and expressed
n mV (21).
ung injury. Mice were anesthetized (sodium pentobarbi-
al 65 mg/kg IP) for bronchoalveolar lavage fluid (BALF),
ung tissue samples, and histological studies. In the first
eries of experiments, the lungs were harvested, weighed,
nd then dried to constant weight at 80°C over 48 h in an
ven. To assess tissue edema, the wet/dry ratio was calcu-
ated. In the second series of experiments, BALF was
arvested from the lung after tracheal intubation (percent-
ge of fluid recovered: from 85% to 90%). Protein concen-
ration in BALF was measured with the Bradford method.
n the third series of experiments, lungs were harvested for
yeloperoxidase (MPO) activity, which was used as an
ndex of leukocyte infiltration. Briefly, after lung homog-
nate preparation, MPO activity was determined spec-
rophotometrically (650 nm) by measuring hydrogen
eroxide-dependent oxidation of 3,3=,5,5=-tetramethyl-
enzidine (22). In the last series of experiments, lungs
ere fixed, embedded in paraffin, and the sections were
tained with hematoxylin and eosin. Two observers, un-
ware of the nature of the experiment, scored the lung injury
nder light microscopy from 0 (no damage) to 4 (maximum
amage), according to the combined assessment of alveolar
ongestion, hemorrhage, edema, infiltration/aggregation of
eutrophils in the airspace or vessel wall, thickness of the
lveolar wall, and hyaline membrane formation.
lasma levels of nitrite/nitrate and immunoblotting. Plasma
evels of nitrite/nitrate, an indicator of nitric oxide synthesis,
ere measured by the Griess reaction, as previously de-
cribed (22).
Isolated mitochondrial protein (50 g) was run on a 12%odium dodecyl (lauryl) sulfate-polyacrylamide gel (SDS-
(
iAGE). The proteins in the gel were electrophoretically
ransferred to nitrocellulose membranes. After blocking,
embranes were treated with a rabbit polyclonal anti Bcl-2
ntibody (Santa Cruz Biotechnology, California). Mem-
ranes were incubated with horseradish peroxidase-
onjugated sheep anti-rabbit immunoglobulin G (IgG)
econdary antibody (Biorad, Marnes-la-Coquette, France).
embranes were then washed, and bound antibodies were
etected by the use of ECL Plus kit (Amersham Biosciences
urope GmbH, Freiburg, Germany) (23).
aspase-like activities. After incubation in assay buffer
ontaining (in mmol/l) HEPES 50, NaCl 100, EDTA 1,
igure 2. Cardiac function of sham and cecal ligation and puncture (CLP)
ild-type mice and transgenic mice overexpressing B-cell leukemia (Bcl).
A) Left ventricular (LV) tension and (B) maximal increases in pressure
dF/dt max) values were recorded after a 30-min equilibration period.
ample size is 12 in each group. Results are expressed as means  SEM
nd analyzed by means of one-way analysis of variance and Bonferroni’s
ultiple comparison post hoc adjustment. *p  0.005 versus sham mice
Bonferroni adjusted; ten comparisons). †p  0.005 versus CLP mice
Bonferroni adjusted; ten comparisons). NIM811  N-methyl-4-
soleucine cyclosporine.
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g/ml) aprotinin 10, leupeptin 10, and pepstatin 10 at pH
.32, homogenized hearts were lysed with a Kontes Glass.
roteins (200 g) were diluted in 200 l of assay buffer;
hen either N-acetyl-Asp-Glu-Val-Asp-AMC (7-amino-
-methylcoumarin) or N-acetyl-Leu-Glu-His-Asp-AMC
7-amino-4-methylcoumarin) (50 mol/l; Biomol, Plym-
uth Meeting, Pennsylvania) was added. Sample fluores-
ence (excitation: 380 nm; emission 437 nm) was measured
t 2 h (Spex Fluoromax, Isa-Horiba, Longjumeaux, France)
23).
tatistics. Results were analyzed with the SPSS for Win-
ows software, version 11.0.1 (SPSS France, Paris-la-
éfense, France). Data represent means  SEM and were
nalyzed by analysis of variance procedures. When a signif-
cant difference was found, we identified specific differences
etween groups with a sequentially rejective Bonferroni
rocedure. After application of the Bonferroni correction,
 0.05 was taken as a level of statistical significance.
urvival was evaluated with Fisher exact test.
ESULTS
epsis model characteristics. In an independent series of
xperiments (n  12 septic mice), we observed that wild-
ype mice began to die between 6 and 12 h after CLP
urgery. Maximum mortality rate (75%) was observed 48 h
fter CLP and remained stable at 96 h. Mortality rate of
0% was achieved at 18 to 24 h. Consequently, physiolog-
cal and biological studies were performed at this time point.
t the time of sacrifice, all CLP mice exhibited clinical signs
f sepsis, including severe hypoactivity and shivering. The
mount of Bcl-2 in heart mitochondria of C57Bl/6 mice
nd Bcl-2 transgenic mice was assessed by Western blot
nalysis. The Bcl-2 mitochondrial protein levels of trans-
enic mice were three-fold higher than wild-type mice (data
ot shown).
yclosporine treatment and Bcl-2 overexpression im-
roved survival in septic mice. Survival studies included
2 mice in each treatment group and were performed twice.
o determine the effects of immunosuppressive and non-
mmunosuppressive analogs of cyclosporine, CsA, NIM811,
nd tacrolimus were injected in saline immediately after
LP surgery. Sham mice received equal doses of saline. As
hown in Figures 1A and 1B, CsA (2 mg/kg) and NIM811
Table 1. Lung Injury Parameters in Sham and
Sham
BALF* protein (g/ml) 65  8
Lung wet/dry ratio 4.60  0.06
Lung MPO (OD650) 0.15  0.04
Histology lung injury score 0.5  0.5
Score (0–4), on the basis of edema, hemorrhage, thickenin
alveolar spaces. Sample size is 6 in each group. Results were an
comparison post hoc adjustment. *Bronchoalveolar lavage
comparisons). ‡p  0.008 versus CLP mice (Bonferroni adjBALF  bronchoalveolar lavage fluid; CLP  cecal ligation an
myeloperoxidase activity; NIM811  N-methyl-4-isoleucine cyclo2 mg/kg) fully protected mice against CLP-induced mor-
ality. A consistent level of protection was obtained with
sA (10 mg/kg) and NIM811 (10 mg/kg), whereas a
00-mg/kg-dose regimen had deleterious effects on mortal-
ty rate in CLP mice (Figs. 1A and 1B). Tacrolimus FK 506
a potent immunosuppressive drug that has no effects on
itochondrial permeability transition) (2 mg/kg) had dele-
erious effects on CLP-induced mortality (mortality rate 
%; data not shown). Cyclosporine analogs had no effects on
ortality rate in sham mice (Figs. 1A and 1B). In a separate
eries of experiments, CLP was initiated in Bcl-2 trans-
enic mice and wild-type mice as controls. The difference
n survival between these two groups was apparent,
ecause only 25% of the wild-type mice compared with
0% of the Bcl-2 transgenic mice were still alive 96 h
fter CLP (Fig. 1C).
yclosporine and Bcl-2 overexpression improved organ
ysfunction in septic mice. Baseline heart contractile
unction was similar in wild-type and Bcl-2 transgenic mice
Figs. 2A and 2B). Cecal ligation and puncture induced
ignificant myocardial contractile dysfunction in wild-type
ice compared with wild-type sham mice. Treatments with
yclosporine analogs (CsA and NIM811; 2 mg/kg) reduced
LP-induced contractile dysfunction (Fig. 2A). The Bcl-2
ransgenic mice were also protected against CLP-induced
ontractile dysfunction (Fig. 2B). Hearts from CLP-treated
cl-2 transgenic mice (Fig. 2B) showed major increases in
aximal, developed left ventricular pressure and dP/dtmax
ompared with CLP wild-type mice.
Effects of cyclosporine analogs (CsA and NIM811; 2
g/kg) in CLP mice were evaluated on BALF protein
oncentration and lung wet/dry weight ratio, MPO activity,
nd histopathologic grading (Table 1). Treatments with
sA and NIM811 (2 mg/kg) in sham had no effects on the
forementioned lung function parameters (data not shown).
yclosporine A and NIM811 (2 mg/kg) largely prevented
LP-induced increases in BALF protein concentration,
ung MPO activity, and histological injury score (Table 1).
yclosporine and Bcl-2 overexpression improved mito-
hondrial function in septic heart. First, high purity and
uter membrane integrity of isolated mitochondria were
easured as undetectable activity levels of, respectively,
ADPH-cytochrome c reductase, a specific reticulum
Septic Mice
LP CLP CsA CLP NIM811
 4† 80  5†‡ 75  5†‡
 0.34† 4.91  0.06† 4.83  0.03†
 0.08† 0.32  0.07†‡ 0.28  0.02†‡
 0.5† 1.5  0.5†‡ 2.0  0.5†‡
he alveolar wall, and infiltration of inflammatory cells into
with one-way analysis of variance and Bonferroni’s multiple
†p  0.008 versus sham mice (Bonferroni adjusted; six
six comparisons).CLP
C
125
5.35
0.61
3.5
g of t
alyzed
fluid.
usted;d puncture; CsA  cyclosporine A; MPO  homogenate
sporine; OD  optical density.
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rane marker enzyme.
In C57Bl/6 wild-type CLP mice, RCR (increases in state
and reduction in state 3) at 18 h was reduced with no
hanges in maximum flux through the isolated step of
omplex IV dependent respiration (Table 2). In CLP mice,
yclosporine analog treatments and Bcl-2 overexpression
esulted in improvement of RCR. Cyclosporine A reduced
tate 4 respiration and partially increased state 3 respiration,
ith no changes in maximum oxygen flux. The NIM811
reatment and Bcl-2 overexpression resulted in major in-
reases in state 3 respiration, state 4 respiration, and
aximum oxygen flux. In sham mice, cyclosporine analog-
reated sham mice, and Bcl-2 transgenic sham mice, no
hanges in respiration parameters were observed 18 h after
urgery (data not shown). In the cyclosporine analog-treated
ham mice and Bcl-2 transgenic sham mice, mitochondrial
igure 3. Representative example of mitochondrial permeability transition i
re displayed in one sham (a), one cecal ligation and puncture (CLP) (b),
Table 2. Respiration Parameters and Membran
Sham CLP
State 4 37  3 48  2*
State 3 470  77 299  70*
RCR 9.7  0.7 6.23  0.3*
Ascorbate TMPD 1688  102 1782  351
m 220  6 190  12*
Sample size is 12 in each group. Results were analyzed with o
post hoc adjustment. *p  0.005 versus sham mice (Bonfe
(Bonferroni adjusted; ten comparisons).
Ascorbate TMPD  N,N,N=,N=-tetramethyl-p-phenylen
mmol/l) and TMPD (0.5 mmol/l) after rotenone complex I i
 respiratory control ratio of state 3 and state 4 respiration ra
diphosphate (ADP) (1 mmol/l); State 4  respiration rate (
in absence of exogenous ADP; other abbreviations as in TabNIM811)-treated CLP (d), and one CLP transgenic mouse (e). In sham mice (
o induce mitochondrial permeability transition versus 80 mol/l Ca2 (8 pulseembrane potential averaged 220 mV (data not shown).
n CLP mice, mitochondrial membrane potential was
nstable and averaged 190 mV (Table 2). Cyclosporine A
r NIM811 CLP mice and CLP Bcl-2 transgenic mice had
table mitochondrial membrane potential, which averaged
210 mV (Table 2).
Representative examples of a mitochondrial permeability
ransition recording are displayed in Figure 3. The amount
f Ca2 added in the cuvette that was required to open the
ore averaged 200 mol/l in the sham mice, which corre-
ponded to 200 nmol/mg mitochondrial protein (Fig. 4). A
imilar amount of Ca2 was required to open the pore in
yclosporine analog-treated sham and Bcl-2 transgenic
ham mice (data not shown). The Ca2 overload was
ignificantly reduced in CLP mice, averaging 60 mol/l
Fig. 4). In CsA-treated or NIM811 CLP-treated mice and
n CLP Bcl-2 transgenic mice, the Ca2 overload required
d by calcium overload in preparation of isolated mitochondria. Recordings
yclosporine-A–treated CLP (c), one N-methyl-4-isoleucine cyclosporine
2 2
tential of Isolated Heart Mitochondria
CLP CsA CLP NIM811 CLP BCL-2
36  3† 69  8*† 86  13*†
434  29† 555  34*† 719  20*†
8.2  1.3*† 8.0  0.2*† 8.4  0.9*†
1432  251 2302  205*† 2689  324*†
207  2 208  2 215  2
y analysis of variance and Bonferroni’s multiple comparison
adjusted; ten comparisons). †p  0.005 versus CLP mice
ine respiration rate (pmol oxygen/s/mg) with ascorbate (2
on; m  mitochondrial membrane potential (mV); RCR
ate 3  respiration rate (pmol oxygen/s/mg) with adenosine
xygen/s/mg) with glutamate (5 mmol/l) malate (2 mmol/l)nduce
one ce Po

ne-wa
rroni
ediam
nhibiti
tes; Sta), a Ca load of 260 mol/l (26 pulses of 10 mol/l Ca ) was required
s of 10 mol/l Ca2) in wild-type CLP mice.
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July 18, 2006:377–85 Mitochondrial Dysfunction in Septic Heartor pore opening significantly increased when compared
ith CLP mice (Fig. 4).
ffects of cyclosporine and Bcl-2 overexpression on
LP-induced plasma nitrite/nitrate levels and effector
aspase activation. Plasma levels of nitrite/nitrate, an in-
icator of NO synthesis, were not increased in CLP mice at
8 h (nitrite/nitrate 15  3 mol/l in sham vs. 22  8
mol/l in CLP mice). Neither cyclosporine analogs (i.e.,
sA and NIM811) nor Bcl-2 overexpression resulted in
hanges in plasma nitrite/nitrate levels in CLP mice (nitrite/
itrate 18  4 mol/l, 16  7 mol/l, and 24  3 mol/l,
espectively). Heart caspase-9–like activities, which were
argely prevented by cyclosporine analog treatment and
cl-2 overexpression in septic mice (Fig. 5), increased in
LP mice at 18 h. Similar caspase-3–like activity increases
ere detected in CLP mice at 18 h; these were also
revented by cyclosporine analog treatment and Bcl-2
verexpression.
ISCUSSION
lthough regional and microvascular perfusion abnormali-
ies undoubtedly occur (1,2), recent investigations indicate
hat metabolism is also altered at the cellular level during
epsis, which might result in impaired cellular use of oxygen
nd organ dysfunction (3). Because mitochondria use 90%
f total body oxygen consumption to generate adenosine
riphosphate, function of vital organs such as the heart could
e impaired as a consequence of abnormalities in mitochon-
igure 4. The Ca2 load required for mitochondrial permeability transi-
ion in sham and CLP wild-type mice and mice overexpressing Bcl-2.
ample size is 12 in each group. Results are expressed as means  SEM
nd analyzed by means of one-way analysis of variance and Bonferroni’s
ultiple comparison post hoc adjustment. *p  0.005 versus sham mice
Bonferroni adjusted; ten comparisons). †p  0.005 versus CLP mice
Bonferroni adjusted; ten comparisons). Abbreviations as in Figure 2.rial bioenergetic processes. Here, we report the new, important information that improvement of mitochondrial
unction via permeability transition inhibition reduces heart
nd lung dysfunction and mortality in septic mice. To the
est of our knowledge, the present report is the first to
emonstrate that mitochondrial permeability transition
ight be directly responsible for vital organ dysfunction and
ortality in chronic septic in mice.
The immunosuppressant drug CsA, which interacts with
yclophilin D, inhibits mitochondrial permeability transi-
ion (14,15). In isolated mitochondria, CsA prevents swell-
ng and increases mitochondrial calcium retention capacity
11–13). In vivo, the inhibitory effect of CsA emphasized
he critical importance of permeability transition pore in
rgan injury induced by ischemia reperfusion. At micromo-
ar concentrations, CsA might significantly decrease infarct
ize in ischemia reperfusion of the heart (14,15) and the
rain (24), whereas millimolar concentrations might cause
rgan toxicity though excessive free radical generation (25).
ikewise, findings from our study and from other groups
26) suggest that treatment with high doses of CsA exac-
rbates mortality in CLP septic mice. Conversely however,
e (27) and other groups (6,28) have reported that lower
oncentrations of CsA might attenuate tissue injury and
bnormalities in mitochondrial function and protect against
ndotoxin-mediated myocardial dysfunction. Here, we pro-
ide the first evidence that cyclosporine derivatives and
cl-2 overexpression fully afforded CLP septic mice protec-
ion against heart and lung derangements, which was
ssociated with increased survival rate.
Among the deleterious changes induced by sepsis on vital
rgan function, impaired myocardial performance is a well-
ocumented feature that greatly contributes to mortality
1,2). Although sepsis is generally viewed as a disease
ggravated by an inappropriate inflammatory response to
acteria, implication of apoptosis has been recently demon-
trated in the pathogenesis of sepsis (29). Moreover, we
ave demonstrated that activation of heart apoptosis path-
ays might directly impede ventricular contractile function
ia caspase-induced sarcomere disarray (23). Here, our
esults suggest that mitochondrial permeability transition, a
ajor event in apoptotic mitochondrial pathway (10), is
mplicated in septic ventricular contractile dysfunction
ia abnormalities in heart mitochondrial bioenergetics.
itochondrial permeability transition and dissipation of
embrane potential induced by CLP sepsis were associ-
ted with impaired respiratory capacity under phosphor-
lating conditions (state 3) and respiration increases
nder non-phosphorylating conditions (state 4), which
ead to reduced RCR (state 3/state 4 respiratory rates). In
ontrast, reductions in RCR were prevented by cyclo-
porine analogs and overexpression of Bcl-2; this indi-
ates global improvement of mitochondrial functional
ntegrity. Our results are thus consistent with recent
tudies suggesting that sepsis-mediated mitochondrial
njury correlates with impaired respiration efficacy of
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Mitochondrial Dysfunction in Septic Heart July 18, 2006:377–85itochondria, which was prevented by cyclosporine de-
ivatives (6,28).
Limitations of the study are mainly that treatment with
yclosporine analogs and Bcl-2 overexpression might im-
rove organ dysfunction and survival in sepsis through
echanisms independent of mitochondrial permeability
ransition. For example, overexpression of Bcl-2 and CsA
reatment might be beneficial in different models of sepsis
ia reduction in proinflammatory mediator synthesis and
ymphocyte apoptosis. Here, we observed that neither cy-
losporine analogs nor overexpression of Bcl-2 in CLP mice
ltered plasma nitrite/nitrate and TNF-alpha (S. Lancel,
npublished data, January 2005) levels. Beneficial effects of
reatment with cyclosporine analogs could also be attributed
o their known effects on calcineurin pathways. However,
he fact that CsA and NIM811 (a non-immunosuppressive
rug that inhibits mitochondrial permeability transition)
igure 5. (A) Representative caspase-9–like (LEHDase) and (B) caspase-
ice and mice overexpressing Bcl-2. Inset panel presents LEHDase maxi
s means SEM of in each group (sample size is 12 in each group). Results
omparison post hoc adjustment. *p  0.005 versus sham mice (Bonferron
0 comparisons). Abbreviations as in Figure 2.ut not tacrolimus (a potent immunosuppressive drug that aas no effects on mitochondrial permeability transition)
ere able to offer protection suggests that reduction in
epsis-induced myocardial dysfunction and mortality rate is
elated to the unique effects of cyclosporine derivatives on
he mitochondrial function. We have shown that, during
ndotoxemia, increased heart caspase-3–like activity could
articipate directly in myocardial dysfunction. Here, in-
reases in caspase-9– and -3–like activities were detected in
he hearts of CLP mice. Reduction in caspase-3–like
ctivities in CLP mice treated with cyclosporine analogs and
verexpression of Bcl-2 could account at least in part for
bserved beneficial effects on heart function.
In conclusion, our study provides strong evidence that
eptic vital organ dysfunction can be prevented by inhibiting
itochondrial permeability transition. Regarding the criti-
al role of heart failure in the pathophysiology of septic
hock, our study also indicates a potentially new therapeutic
(DEVDase) activities in heart left ventricle of sham and CLP wild-type
uorescence intensity (counts per second [cps]) measured (em  437 nm)
nalyzed by means of one-way analysis of variance and Bonferroni’s multiple
sted; 10 comparisons). †p  0.005 versus CLP mice (Bonferroni adjusted;3–like
mal fl
are approach for treatment of sepsis syndrome.
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